INK4a and conventionally counterstained with haematoxylin. The intensity of immunostaining in cases of squamous intraepithelial lesion (SIL) was assessed using a 0-3 scoring system. Interobserver agreement was calculated by k statistics. Results: Expression of p16INK4a was detected in 3 of 23 cases of WNL, 4 of 6 cases of LSIL, all cases of HSIL, 5 of 16 cases of ASC-US and 13 of 16 cases of ASC-H. Excluding two cases with no residual dysplastic cells in the immunocytochemistry, all cases of cervical intraepithelial neoplasia (CIN)2 or CIN3 at follow-up expressed p16INK4a and none of the p16 INK4a -negative cases showed a high-grade lesion at follow-up. No evident differences in pattern or intensity of p16INK4a expression were observed between the specimens of the study and control groups. Interobserver agreement was significantly better in the study group than in the group with conventional immunostaining (combined k 0.773 v 0.549; p,0.05), and still better, albeit statistically not significant, than with conventional immunostaining and cervical smear test together (combined k 0.773 v 0.642). Conclusion: Immunocytochemistry with p16INK4a and modified Papanicolaou counterstain may add to the cervicovaginal cytology the full potentiality of p16INK4a without the need of a further slide and the risk of loss of dysplastic cells, yet maintaining the typical morphological features of the smear test.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.